Fiche centre
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai — China
Essais liés2clinical trials
VilleShanghailocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT01703780
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| TJ0113 200mg | Parkinson | Phase 3 | NCT07741045 | Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease | NOT_YET_RECRUITING |
| doublepres — The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis | Hypertension | À vérifier | NCT01703780 | doublepres — The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis | UNKNOWN |